Telesis Bio

About Telesis Bio

Telesis Bio is dedicated to enabling researchers to accelerate therapeutic discovery through advanced, rapid, and flexible automated RNA and DNA workflows in their own labs. Their mission is to eliminate outsourcing delays and boost productivity by providing on-site synthesis of high-fidelity DNA and mRNA using the Gibson SOLA platform, supporting innovations in synthetic biology and therapeutic discovery across biotech and pharma.

Products & Services

BioXp Platform:An automated synthetic biology platform including BioXp systems (3250 and 9600) and kits for mRNA synthesis, gene synthesis, DNA cloning, DNA amplification, libraries, and NGS library preparation.

Gibson SOLA Platform:A custom solution for rapid on-site DNA and gene synthesis, designed to integrate with lab automation, giving scientists control over build timelines and IP.

Specialties

Synthetic Biology Therapeutic Discovery DNA and mRNA Synthesis Automated RNA and DNA Workflows Antibody Drug Discovery Cell and Gene Therapy Vaccine Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Preferred Stock T: - FT: Convertible Preferred Stock	A: 21000000 MR: - FA: up to $21 million FAN: 21000000	D: 2025-03-18 FD: 2025-03-18	2 investors
2	RT: Private Placement T: - FT: Private Placement	A: 28000000 MR: - FA: $28.0 million FAN: 28000000	D: 2023-06-05 FD: 2023-06-05	4 investors
3	RT: Private Placement T: - FT: Private Placement	A: 28000000 MR: - FA: $28.0 million FAN: 28000000	D: 2023-05-31 FD: 2023-05-31	4 investors

Convertible Preferred Stock Latest

2025-03-18

$21.0M

2 investors (Pro only)

Private Placement 2023-06-05

$28.0M

Private Placement 2023-05-31

$28.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eric Esser

President, Chief Executive Officer and Chairman of the Board of Directors

M

Michael Nemzek

Chief Commercial Officer

D

Daniel G. Gibson

Chief Technology Officer

R

Rocky McDonald

Vice President, Finance

K

Krishna Kannan, PhD, MBA

Vice President, Product and Operations

G

Greg Herrema

Senior Advisor, Novalis LifeSciences

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Telesis Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised